WHO ICTRP trial
Effect of probiotic and selenium co-supplementation in the treatment of…
IRCT20170513033941N41 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20170513033941N41 |
|---|---|
| Public title | Effect of probiotic and selenium co-supplementation in the treatment of schizophrenia patients |
| Scientific title | The effects of combined probiotic and selenium supplementation on clinical status and metabolic profiles in patients with schizophrenia |
| Primary sponsor | Arak University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Schizophrenia. Schizophrenia |
| Interventions | Intervention 1: Intervention group: Probiotic oral capsule containing four strains of Lactobacillus acidophilus (2×109 CFU/g), Bifidobacterium lactis (2×109 CFU/g), Bifidobacterium bifidum (2×109 CFU/g) and bifidobacterium longum (2×109… |
| Registration date | Nov 18, 2018 |
| Target size | 60 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: